Viewing Study NCT05029427



Ignite Creation Date: 2024-05-06 @ 4:34 PM
Last Modification Date: 2024-10-26 @ 2:12 PM
Study NCT ID: NCT05029427
Status: COMPLETED
Last Update Posted: 2023-01-26
First Post: 2021-08-26

Brief Title: Effect of Oat Beta Glucan in Managing Blood Pressure
Sponsor: University of Manitoba
Organization: University of Manitoba

Study Overview

Official Title: Effect of Oat Beta Glucan in Managing Blood Pressure a Randomized Cross-over Pilot Trial
Status: COMPLETED
Status Verified Date: 2023-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This is a randomized double-blinded cross-over pilot study comparing the effects of ingesting oats containing high molecular weight β-glucan in reducing blood pressure
Detailed Description: The pilot study will consist of 2 study periods one treatment period and one control period The treatment period will provide food products made from oats containing a total of 4 grams per day high molecular weight HMW oat β-glucan whereas the control period will provide food products made primarily from wheat with no β-glucan The study will be located at the Chronic Disease Innovation Centre in Seven Oaks General Hospital Winnipeg Canada

The primary objective of this study is to investigate the effect of ingestion of HMW oat β-glucan on ambulatory blood pressure Participants will be asked to wear an ambulatory blood pressure monitor for 24 hours per day for 3 consecutive days at the beginning and end of each treatment period This device automatically measures blood pressure every 15-30 minutes during the day and 30 to 60 minutes during the evening

The study has been designed to be conducted virtually Participants will consent to receive both treatment and control over two 4-week periods online The participants will be randomized to different orders of treatment with a 4 week wash out period in between

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None